Related references
Note: Only part of the references are listed.Function of cytoplasmic histone deacetylase 5 is required for HIF-1α stability
Shuyang Chen et al.
CANCER RESEARCH (2012)
Circulating Soluble CD30 and Future Risk of Lymphoma; Evidence from Two Prospective Studies in the General Population
Roel Vermeulen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study
Anil K. Chaturvedi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Circulating tumor cell capture on a microfluidic chip incorporating both affinity and size
Keith Merdek et al.
CANCER RESEARCH (2011)
Tumor Necrosis Factor (TNF) and Lymphotoxin-α (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
Christine F. Skibola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance
Hiromichi Wada et al.
ATHEROSCLEROSIS (2010)
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
Yian Gu et al.
CANCER CAUSES & CONTROL (2010)
Plasma Cytokines and Future Risk of Non-Hodgkin Lymphoma (NHL): A Case-Control Study Nested in the Italian European Prospective Investigation into Cancer and Nutrition
Fatemeh Saberi Hosnijeh et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
TNF receptor 2 pathway: drug target for autoimmune diseases
Denise Faustman et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma
Mark P. Purdue et al.
BLOOD (2009)
TRAIL receptor mediates inflammatory cytokine release in an NF-kappa B-dependent manner
Wanhu Tang et al.
CELL RESEARCH (2009)
Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis
Chun Chao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia
Andrea Buerkle et al.
BLOOD (2007)
Pro-posed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Lindsay M. Morton et al.
BLOOD (2007)
Aberrant NF-kappa B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Philipp J. Jost et al.
BLOOD (2007)
Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients
Faruk Tas et al.
MELANOMA RESEARCH (2006)
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia
S Faderl et al.
BLOOD (2005)
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma:: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
F Rubio-Moscardo et al.
BLOOD (2005)
TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma
M Batten et al.
JOURNAL OF IMMUNOLOGY (2004)
Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia
J Jacobi et al.
CIRCULATION (2004)
CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells
H Husson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
M Shibuya
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
RB Hayes et al.
CONTROLLED CLINICAL TRIALS (2000)
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
JK Gohagan et al.
CONTROLLED CLINICAL TRIALS (2000)
Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes
NL Mathy et al.
IMMUNOLOGY (2000)
Share Paper
